Table 3 Silver catalyzed synthesis of benzazepeno[2,1-a]isoquinolines
2 Reviews: (a) D. Enders, C. Grondal and M. R. M. Huttl, Angew.
¨
Chem., Int. Ed., 2007, 46, 1570–1581; (b) D. G. Rivera,
O. E. Vercillo and L. A. Wessjohann, Org. Biomol. Chem.,
2008, 6, 1787–1795; (c) L. F. Tietze and N. Rackelmann, Pure
Appl. Chem., 2004, 76, 1967–1983; (d) A. Ulaczyk-Lesanko and
D. G. Hall, Curr. Opin. Chem. Biol., 2005, 9, 266–276;
(e) L. F. Tietze, Chem. Rev., 1996, 96, 115–136.
3 For reviews on selected examples see e.g.: (a) D. A. Horton,
G. T. Bourne and M. L. Smythe, Chem. Rev., 2003, 103,
893–930; (b) S. Brase, C. Gil and K. Knepper, Bioorg. Med. Chem.,
¨
2002, 10, 2415–2437.
4 Selected examples from our labs: (a) A. Noren-Muller, W. Wilk,
¨
¨
Yielda
K. Saxena, H. Schwalbe, M. Kaiser and H. Waldmann, Angew.
Chem., Int. Ed., 2008, 47, 5973–5977; (b) A. Noren-Muller,
I. Reis-Correa, Jr., H. Prinz, C. Rosenbaum, K. Saxena,
´
Entry
No.
R1
X
R2
R3
(%, A/B)b
¨
¨
1
2
3
4
5
6
7
11a
11b
11c
11d
11e
11f
11g
H
H
–Ph–
H
H
CH
CH
N
CH
CH
CH
CH
Ph
H
H
H
Et
Et
Et
Et
72/89
58/82
42/72
75/90
68/87
59/n.i.
n.i./69
nPr
Ph
H. J. Schwalbe, D. Vestweber, G. Cagna, S. Schunk, O. Schwarz,
H. Schiewe and H. Waldmann, Proc. Natl. Acad. Sci. U. S. A., 2006,
103, 10606–10611; (c) C. Rosenbaum, P. Baumhof, R. Mazitschek,
Ph
O. Muller, A. Giannis and H. Waldmann, Angew. Chem., Int. Ed.,
¨
3-OMe-Ph
H
4-CF3-Ph
2004, 43, 224–228; (d) H. Waldmann, G. V. Karunakar and
K. Kumar, Org. Lett., 2008, 10, 2159–2162.
H
OMe
5 For selected examples see: (a) S. Su and J. A. Porco, Jr., J. Am.
Chem. Soc., 2007, 129, 7744–7745; (b) S. Su and J. A. Porco, Jr.,
Org. Lett., 2007, 9, 4983–4986; (c) N. Asao, S. Yudha, T. Nogami
and Y. Yamamoto, Angew. Chem., Int. Ed., 2005, 44, 5526–5528;
(d) N. Asao, K. Iso and S. Yudha, Org. Lett., 2006, 8, 4149–4151;
(e) Q. Ding and J. Wu, Org. Lett., 2007, 9, 4959–4962; (f) Q. Ding,
X. Yu and J. Wu, Tetrahedron Lett., 2008, 49, 2752–2755;
(g) W. Sun, Q. Ding, X. Sun, R. Fan and J. Wu, J. Comb. Chem.,
2007, 9, 690–694; (h) R. Yanada, S. Obika, H. Kono and
Y. Takemoto, Angew. Chem., Int. Ed., 2006, 45, 3822–3825;
(i) K. Gao and J. Wu, J. Org. Chem., 2007, 72, 8611–8613;
(j) S. Obika, H. Kono, Y. Yasui, R. Yanada and Y. Takemoto,
J. Org. Chem., 2007, 72, 4462–4468; (k) M. Yu, Y. Wang, C.-J. Li
and X. Yao, Tetrahedron Lett., 2009, 50, 6791–6794.
a
b
= not investigated). Method A: AgOTf
Isolated yields (n.i.
(20 mol%), 2,6-lutidine (1.0 equiv.), ethanol, 60 1C, 24 h; Method B:
AgOTf (2.5 mol%), 2.6-lutidine (10 mol%), ethanol, MW (150 W),
150 1C, 45 min.
6 Reviews: (a) E. Jimenez-Nunez and A. M. Echavarren, Chem.
´
Rev., 2008, 108, 3326–3350; (b) V. Michelet, P. Y. Toullec and
J. P. Genet, Angew. Chem., Int. Ed., 2008, 47, 4268–4315; (c) A. S. K.
Hashmi, Chem. Rev., 2007, 107, 3180–3211; (d) S. F. Kirsch,
Synthesis, 2008, 3183–3204; (e) N. T. Patil and Y. Yamamoto, Chem.
Rev., 2008, 108, 3395–3442; (f) P. Belmont and E. Parker, Eur. J. Org.
Chem., 2009, 6075–6089.
7 (a) K. W. Bentley, The Isoquinoline Alkaloids, Harwood Academic,
Australia, 1998, vol. 1; (b) K. W. Bentley, Nat. Prod. Rep., 2006,
23, 444–463; (c) M. Chrzanowska and M. D. Rozwadowska,
Chem. Rev., 2004, 104, 3341–3370.
8 M. I. Goldbrunner, G. Loidl, T. Polossek, A. Mannschreck and
E. von Angerer, J. Med. Chem., 1997, 40, 3524–3533.
9 (a) D. M. Roll, C. M. Ireland, H. s. M. Lu and J. Clardy,
´ ´
J. Org. Chem., 1988, 53, 3276–3278; (b) C. Jimenez, E. Quinoa,
M. Adamczeski, L. M. Hunter and P. Crews, J. Org. Chem., 1991,
56, 3403–3410.
Scheme 4 Synthesis of homofascaplysin C and fascaplysin.
To overcome the difficult reduction of the tert-butyl ester 13
to final product 14, aniline 15 was employed in the cascade
synthesis of pentacyclic core 16 which was obtained in 61%
yield.13 Formylation of 16 with POCl3 cleanly provided homo-
fascaplysin C with an overall yield of 53%.10a In addition, the
pentacyclic core 16 was efficiently transformed to the natural
product fascaplysin by oxidation with peracetic acid, followed
by salt formation in 52% overall yield (Scheme 4).10a
10 Selected syntheses efforts: (a) G. W. Gribble and B. Pelcman,
J. Org. Chem., 1992, 57, 3636–3642; (b) D. S. Carter and D. L. Van
Vranken, J. Org. Chem., 1999, 64, 8537–8545; (c) C. Aubry,
P. R. Jenkins, S. Mahale, B. Chaudhuri, J.-D. Marechalc and
´
In conclusion we have developed an efficient one-pot, four-
step silver catalyzed cascade sequence that gives ready access to a
variety of skeletally diverse natural product inspired compound
classes including fascaplysin-type alkaloids. This method will
facilitate the synthesis and biological investigation of skeletally
and structurally diverse alkaloid-based compound collections.
M. J. Sutcliffe, Chem. Commun., 2004, 1696–1697;
(d) S. V. Dubovitskii, Tetrahedron Lett., 1996, 37, 5207–5208;
(e) M. E. Zhidkov, O. V. Baranova, N. N. Balaneva,
S. N. Fedorov, O. S. Radchenkob and S. V. Dubovitski,
Tetrahedron Lett., 2007, 48, 7998–8000.
11 Selected reports on biological activities: (a) C. Aubry, A. J. Wilson,
D. Emmerson, E. Murphy, Y. Y. Chan, M. P. Dickens,
M. D. Garcı
Med. Chem., 2009, 17, 6073–6084; (b) S. Mahale, C. Aubry,
A. J. Wilson, P. R. Jenkins, J.-D. Marechal, M. J. Sutcliffec and
´
a, P. R. Jenkins, S. Mahale and B. Chaudhuri, Bioorg.
Notes and references
´
1 (a) K. Kumar and H. Waldmann, Angew. Chem., Int. Ed., 2009, 48,
3224–3242; (b) J. P. Nandy, M. Prakesch, S. Khadem, P. T. Reddy,
U. Sharma and P. Arya, Chem. Rev., 2009, 109, 1999–2060;
(c) G. M. Cragg, P. G. Grothaus and D. J. Newman, Chem.
Rev., 2009, 109, 3012–3043; (d) R. Breinbauer, I. R. Vetter and
H. Waldmann, Angew. Chem., Int. Ed., 2002, 41, 2878–2890; (e) for
a diversity oriented synthesis (DOS) approach see: R. J. Spandl,
M. Diaz-Gavilan, M. G. K. O’Connell, G. L. Thomas and
D. R. Spring, Chem. Rec., 2008, 8, 129–142 and references therein.
B. Chaudhuri, Bioorg. Med. Chem. Lett., 2006, 16, 4272–4278;
(c) J. Lin, X.-J. Yan and H.-M. Chen, Cancer Chemother.
Pharmacol., 2007, 59, 439–445; (d) A. Huwe, R. Mazitschek and
A. Giannis, Angew. Chem., Int. Ed., 2003, 42, 2122–2138;
(e) A. M. Senderowicz, Oncogene, 2003, 22, 6609–6620.
12 J. H. Ahn, J. I. Song, J. E. Ahn and D. K. An, Bull. Korean Chem.
Soc., 2005, 26, 377–378.
13 Treatment of 13 with TFA led to decomposition and only 10% of
16 could be obtained.
ꢀc
This journal is The Royal Society of Chemistry 2010
4624 | Chem. Commun., 2010, 46, 4622–4624